Search Results for "2nd Vaccine Research And Innovation Conference"
Original Source: 2nd Vaccine Research and Innovation Conference
Investigation of vaccine delivery systems, vaccine targets and improved production methods 11th - 12th July 2012, London EC1, UK
Matching Channels
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.
Management Forum - highest quality conference, seminar and knowledge-based experiences
Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...
Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...
Matching News
The future outlook for innovation – Christian Moser
Vaccine innovation is by its nature the source of evolution within the vaccine industry. What makes a vaccine work? It’s a combination of all the [...]
HIV prevention, vaccine research progressing
In a guest post on the Center for Global Health Policy's "Science Speaks" blog, Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI), and William Snow, director of t...
Groundbreaking germ-fighting vaccine research to be presented at National Biotechnology Conference
A novel vaccine study from South Dakota State University will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' National Biotechnolog...
NIH awards $7.8 million for innovative HIV vaccine approaches
(NIH/National Institute of Allergy and Infectious Diseases) NIAID has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe a...
Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston
"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a no...
Exciting HIV vaccine research with bNAbs overcomes key obstacle
A new technique for vaccine design may help overcome an important obstacle in developing a vaccine against HIV. Researchers at The Scripps Research Institute (TSRI) [...]
Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference
Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious D...
MADRID-MIT M+Vision Consortium hosts Biomedical Innovation Conference 2012
(PLANNER Media) The 2012 Biomedical Innovation Conference -- Building High-Performance Innovation Ecosystems, scheduled for June 5-6 in Madrid, will host the presentation of IDEA2 Madrid, a program de...
Matching PubMed Articles
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference.
ABSTRACT: EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission under the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging fr...
On December 12-13, 2011, the United Nations Office for the Coordination of Humanitarian Affairs (OCHA) hosted a humanitarian policy and research conference on the theme of "Risk, Adaptation and Innova...
This paper seeks to give some preliminary evidence on the potential outcome of the pneumococcal vaccine Advance Market Commitment (AMC), with a focus on its impact on innovation in 'emerging' vaccine...
Vaccine Technology III: An ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010.
